[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Dbv Technologies ADR (DBVT)

Dbv Technologies ADR (DBVT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Dbv Technologies ADR 107 AVENUE DE LA REPUBLIQUE CHATILLON I0 92320 FRA

www.dbv-technologies.com Employees: 125 P: 33-1-55-42-78-78

Sector:

Medical

Description:

DBV Technologies SA is a biopharmaceutical company. It develops products and immunotherapies for the diagnosis and treatment of various food allergies, including milk and peanut. The Company delivers biological immunoactive compounds, such as allergens, to the immune system by targeting the antigen-presenting cells present in skin. DBV Technologies SA is headquartered in Bagneux, France.

Key Statistics

Overview:

Market Capitalization, $K 1,031,107
Enterprise Value, $K 836,937
Shares Outstanding, K 59,208
Float, K 58,580
% Float 98.94%
Short Interest, K 1,801
Short Float 3.04%
Days to Cover 10.05
Short Volume Ratio 0.02
% of Insider Shareholders 1.06%
% of Institutional Shareholders 71.74%

Financials:

Annual Sales, $ 5,640 K
Annual Net Income, $ -146,950 K
Last Quarter Sales, $ 900 K
Last Quarter Net Income, $ -47,600 K
EBIT, $ -168,240 K
EBITDA, $ -165,050 K

Growth:

1-Year Return 79.72%
3-Year Return -11.60%
5-Year Return -71.26%
5-Year Revenue Growth -50.00%
5-Year Earnings Growth 58.33%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.56 on 04/30/26
Next Earnings Date 08/04/26
Earnings Per Share ttm -4.46
EPS Growth vs. Prev Qtr 51.30%
EPS Growth vs. Prev Year 57.58%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%
Most Recent Split 1-5 on 11/29/24

DBVT Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -129.88%
Return-on-Assets % -88.84%
Profit Margin % -2,605.50%
Debt/Equity 0.00
Price/Sales 173.76
Price/Cash Flow N/A
Price/Book 4.30
Book Value/Share 3.73
Interest Coverage -3.07
60-Month Beta -0.99
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.